ZA702530B - Improvements relating to pharmaceutical compositions comprising beta-adrenolytics - Google Patents

Improvements relating to pharmaceutical compositions comprising beta-adrenolytics

Info

Publication number
ZA702530B
ZA702530B ZA702530A ZA702530A ZA702530B ZA 702530 B ZA702530 B ZA 702530B ZA 702530 A ZA702530 A ZA 702530A ZA 702530 A ZA702530 A ZA 702530A ZA 702530 B ZA702530 B ZA 702530B
Authority
ZA
South Africa
Prior art keywords
adrenolytics
beta
pharmaceutical compositions
improvements relating
relating
Prior art date
Application number
ZA702530A
Other languages
English (en)
Inventor
A Engelhardt
H Koeppe
K Zeile
H Morr
A Lichterfeld
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of ZA702530B publication Critical patent/ZA702530B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA702530A 1969-04-16 1970-04-15 Improvements relating to pharmaceutical compositions comprising beta-adrenolytics ZA702530B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691919342 DE1919342A1 (de) 1969-04-16 1969-04-16 Herzwirksame Kombinationspraeparate

Publications (1)

Publication Number Publication Date
ZA702530B true ZA702530B (en) 1971-01-27

Family

ID=5731393

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA702530A ZA702530B (en) 1969-04-16 1970-04-15 Improvements relating to pharmaceutical compositions comprising beta-adrenolytics

Country Status (8)

Country Link
BE (1) BE748820A (xx)
CA (1) CA940048A (xx)
DE (1) DE1919342A1 (xx)
FR (1) FR2042334B1 (xx)
GB (1) GB1305644A (xx)
IE (1) IE34187B1 (xx)
NL (1) NL7005435A (xx)
ZA (1) ZA702530B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000282A (en) 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
LU76150A1 (xx) * 1976-11-08 1978-07-10
FR2401661A1 (fr) * 1977-08-29 1979-03-30 Italiana Med Sint Compositions pharmaceutiques a base de medicaments anxiolytiques et d'inhibiteurs du systeme b-adrenergique
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
DE2926653A1 (de) * 1979-07-02 1981-01-22 Sandoz Ag Neue therapeutische verwendung von organischen verbindungen
US4416735A (en) 1982-06-17 1983-11-22 Eastman Kodak Company Diluent and method for potentiometric assay of liquids
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents

Also Published As

Publication number Publication date
GB1305644A (xx) 1973-02-07
FR2042334B1 (xx) 1974-08-30
CA940048A (en) 1974-01-15
BE748820A (fr) 1970-10-12
IE34187L (en) 1970-10-16
FR2042334A1 (xx) 1971-02-12
DE1919342A1 (de) 1970-12-03
IE34187B1 (en) 1975-03-05
NL7005435A (xx) 1970-10-20

Similar Documents

Publication Publication Date Title
AU458705B2 (en) Improvements in or relating to pharmaceutical compositions
ZA713539B (en) Pharmaceutical compositions
ZA705411B (en) Improvement relating to beta-aryl-2-aminoalkoxy-styrenes
ZA717083B (en) New pharmaceutical compositions
MY7700200A (en) Pharmaceutical compositions
ZA702530B (en) Improvements relating to pharmaceutical compositions comprising beta-adrenolytics
CA930306A (en) Pharmaceutical compositions
MY7400119A (en) Pharmaceutical compositions comprising lincomycin derivatives
CY845A (en) Antiineectious pharmaceutical compositions
GB1373913A (en) Pharmaceutical compositions
ZA715832B (en) Pharmaceutical compositions
CA930305A (en) Pharmaceutical compositions
ZA704998B (en) Pharmaceutical compositions
ZA708508B (en) Therapeutic compositions
ZA695903B (en) Pharmaceutical compositions
ZA716461B (en) Pharmaceutical compositions
AU1347370A (en) Improvements in or relating to therapeutic compositions
IL33808A0 (en) Pharmaceutical composition comprising phenylbutazon
IE34882L (en) Pharmaceutical composition
ZA704677B (en) Therapeutic compositions
ZA704678B (en) Therapeutic compositions
AU439713B2 (en) Pharmaceutical compositions
AU435541B2 (en) Pharmaceutical compositions
AU442181B2 (en) Pharmaceutical compositions
CA807196A (en) Pharmaceutical compositions